Aurobindo Pharma's US subsidiary has partnered with a global pharmaceutical company to develop and sell respiratory products. The collaboration involves a shared cost of up to $90 million over three to five years, with both companies sharing marketing rights while the unnamed partner handles manufacturing ..read more

360 ONE Asset has acquired a stake in OneSource Specialty Pharma, a Contract Development and Manufacturing Organization (CDMO), for an undisclosed amount. The investment will support OneSource's innovation and global expansion plans. OneSource recently raised $95 million from other investors and is preparing to list its shares on stock exchanges ..read more

Wockhardt founder sought GST exemption for antibiotics discovered in India. He said this will make the drugs more affordable. The statement was made at an event to celebrate the scientific completion of the first indigenously developed antibiotic Nafithromycin. Nafithromycin is the first macrolide antibiotic in 30 years for community-acquired bacterial pneumonia ..read more

"The respiratory market shows the normal seasonal trend for the anti-asthma and cough and cold segment," said Sheetal Sapale, VP, commercial, Pharmarack. "There were fewer reported cases in October 2024 compared to October 2023, hence there is de-growth in the market. The market peaks in December and January and then gradually subsides as winter loses its intensity," Sapale said ..read more

The Supreme Court has instructed Zydus Lifesciences to approach the Delhi High Court. Zydus is seeking relief from an order that prevents the sale of its breast cancer drug, Sigrima. Swiss pharmaceutical giant, Roche, alleges that Sigrima is similar to its own cancer drug. Roche requested the court to prohibit Zydus from selling Sigrima ..read more

Dr Reddy's Laboratories and FDC Ltd issued voluntary recalls for medications in the US market due to manufacturing defects. Dr Reddy's recalled lots of Morphine Sulfate extended-release tablets due to failed impurity specifications, while FDC Ltd recalled Timolol Maleate ophthalmic solution due to defective containers hindering solution dispensing ..read more

Telangana's Genome Valley is attracting substantial investments in life sciences. Over Rs. 36,000 crore was invested in the past year. This resulted in over 140 new projects. These projects include pharmaceutical manufacturing, R&D centers, and vaccine production. International companies are partnering with Indian businesses. The government expects these investments to create thousands of jobs ..read more

Lubrizol, a Berkshire Hathaway company, is partnering with Polyhose to establish a medical tubing manufacturing plant in Tamil Nadu, India. The facility, slated to begin operations in 2026, will significantly increase Lubrizol's production capacity, aiming to serve both domestic and international markets with high-quality medical tubing for various applications ..read more

A new study reveals that over 800 million adults worldwide have diabetes. India leads the world with 212 million cases, followed by China with 148 million. The US has 42 million cases. The global diabetes rate has doubled since 1990. The study used data from over 140 million people across more than 1,000 studies ..read more

Amongst the top 10 therapies that contribute to more than 90% of the Indian pharma market, price drove growth in the cardiac segment. The anti-hypertensives, which account for almost 50% of the cardiac segment, is experiencing stagnated volume growth. Lipid-lowering drugs and platelet aggregation inhibitors have shown a relatively higher growth to help boost the cardiac segment ..read more